Trials / Completed
CompletedNCT01790685
Ozurdex for Retinal Vein Occlusion Study (ORVO Study)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To measure the pro-permeability factors in the aqueous humor of patients with persistent/recurrent macular edema after an injection of Ozurdex.
Detailed description
To measure various pro-permeability factors in the aqueous humor of patients with persistent/recurrent macular edema despite prior treatment with anti-VEGF agents at baseline and at 4 weeks after intraocular injection of OZURDEX.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone implant |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-02-13
- Last updated
- 2015-04-22
- Results posted
- 2015-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01790685. Inclusion in this directory is not an endorsement.